Authors:
BLOK MJ
GOOSSENS VJ
VANHERLE SJV
TOP B
TACKEN N
MIDDELDORP JM
CHRISTIAANS MHL
VANHOOFF JP
BRUGGEMAN CA
Citation: Mj. Blok et al., DIAGNOSTIC-VALUE OF MONITORING HUMAN CYTOMEGALOVIRUS LATE PP67 MESSENGER-RNA EXPRESSION IN RENAL-ALLOGRAFT RECIPIENTS BY NUCLEIC-ACID SEQUENCE-BASED AMPLIFICATION, Journal of clinical microbiology, 36(5), 1998, pp. 1341-1346
Authors:
CHRISTIAANS MHL
OVERHOFDEROOS R
NIEMAN F
VANHOOFF JP
VANDENBERGLOONEN EM
Citation: Mhl. Christiaans et al., DONOR-SPECIFIC ANTIBODIES AFTER TRANSPLANTATION BY FLOW-CYTOMETRY - RELATIVE CHANGE IN FLUORESCENCE RATIO MOST SENSITIVE RISK FACTOR FOR GRAFT-SURVIVAL, Transplantation, 65(3), 1998, pp. 427-433
Authors:
CHRISTIAANS MHL
OVERHOF R
TENHAAFT A
NIEMAN F
VANHOOFF JP
VANDENBERGLOONEN EM
Citation: Mhl. Christiaans et al., NO ADVANTAGE OF FLOW-CYTOMETRY CROSS-MATCH OVER COMPLEMENT-DEPENDENT CYTOTOXICITY IN IMMUNOLOGICALLY WELL-DOCUMENTED RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 62(9), 1996, pp. 1341-1347
Authors:
CHRISTIAANS MHL
TENHAAFT A
NIEMAN F
OVERHOF R
VANHOOFF JP
VANDENBERGLOONEN P
Citation: Mhl. Christiaans et al., FC-XM IN SENSITIZED-CADAVERIC RENAL-TRANSPLANT - CDC-XM STILL THE GOLDEN STANDARD, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1077-1077
Authors:
CHRISTIAANS MHL
VANKOUWEN M
SPIERING W
VANHOOFF JP
Citation: Mhl. Christiaans et al., MAINTENANCE IMMUNOSUPPRESSION IN RENAL-TRANSPLANTATION WITHOUT STEROIDS - UTOPIA OR REALITY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1077-1077
Authors:
CHRISTIAANS MHL
SPIERING W
NIEMAN F
VANHOOFF JP
Citation: Mhl. Christiaans et al., NEPHROTOXICITY OF FK506 VERSUS CYCLOSPORINE-A AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1078-1078
Citation: W. Spiering et al., INFLUENCE OF ACE-INHIBITION ON POST RENAL-TRANSPLANT ERYTHROCYTOSIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1116-1116
Authors:
SPIERING W
CHRISTIAANS MHL
DELEEUW PW
VANHOOFF JP
Citation: W. Spiering et al., INFLUENCE OF ACE-INHIBITION ON HEMOGLOBIN AND HEMATOCRIT IN ESSENTIALHYPERTENSIVE PATIENTS, Nephrology, dialysis, transplantation, 10(7), 1995, pp. 1254-1254
Citation: Yj. Kraat et al., RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION AND DISEASE IN RENAL-TRANSPLANT RECIPIENTS - HLA-DR7 AND TRIPLE THERAPY, Transplant international, 7(5), 1994, pp. 362-367